What does CUSIP 91307C102 represent in this 13F holders report?

CUSIP 91307C102 is the security identifier for UTHR - UNITED THERAPEUTICS Corp - Common Stock used to aggregate holder disclosures.

How many institutions held UTHR - UNITED THERAPEUTICS Corp - Common Stock in Q1 2020?

293 institutional investors reported UTHR - UNITED THERAPEUTICS Corp - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 43,898,805
Total 13F shares: 42,930,204
Share change: +1,770,654
Total reported value: $4,071,608,811
Put/Call ratio: 58%
Price per share: $94.83
Number of holders: 293
Value change: +$175,279,566
Number of buys: 137
Number of sells: 160

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 91307C102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	11%	4,641,085	$408,786,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	9.2%	4,052,047	$356,904,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	8.1%	3,544,433	$312,194,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	5.4%	2,383,549	$209,943,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	4.3%	1,894,825	$166,896,000	—	31 Dec 2019	13F
Palo Alto Investors LP	13F	Company	2.9%	1,288,902	$113,526,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	2.8%	1,231,507	$108,471,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.5%	1,112,923	$98,026,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	2.2%	959,171	$84,484,000	—	31 Dec 2019	13F
Consonance Capital Management LP	13F	Company	2.1%	919,263	$80,969,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2%	884,333	$77,889,000	—	31 Dec 2019	13F
THOMPSON SIEGEL & WALMSLEY LLC	13F	Company	1.9%	837,314	$73,750,000	—	31 Dec 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.8%	787,771	$69,388,000	—	31 Dec 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.7%	750,000	$66,060,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.5%	671,129	$58,610,000	—	31 Dec 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	1.4%	617,574	$54,396,000	—	31 Dec 2019	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	1.3%	554,264	$48,820,000	—	31 Dec 2019	13F
GREAT POINT PARTNERS LLC	13F	Company	1.2%	541,179	$47,667,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	539,689	$47,534,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	1.2%	527,800	$46,489,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	1.2%	521,312	$45,917,000	—	31 Dec 2019	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1.1%	490,420	$43,196,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	1.1%	473,915	$41,743,000	—	31 Dec 2019	13F
Krensavage Asset Management, LLC	13F	Company	1.1%	460,944	$40,600,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.92%	402,003	$35,408,000	—	31 Dec 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.92%	401,832	$35,393,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.84%	366,698	$32,298,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.81%	354,450	$31,220,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.74%	326,437	$28,753,000	—	31 Dec 2019	13F
BRANDES INVESTMENT PARTNERS, LP	13F	Company	0.66%	290,982	$25,629,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.61%	266,834	$23,503,000	—	31 Dec 2019	13F
AJO, LP	13F	Company	0.52%	228,730	$20,146,000	—	31 Dec 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.51%	222,089	$19,562,000	—	31 Dec 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.45%	196,866	$17,340,000	—	31 Dec 2019	13F
LSV ASSET MANAGEMENT	13F	Company	0.45%	196,393	$17,298,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.44%	193,101	$17,008,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.44%	191,249	$16,845,000	—	31 Dec 2019	13F
Sofinnova Investments, Inc.	13F	Company	0.43%	188,645	$16,616,000	—	31 Dec 2019	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.41%	181,600	$15,995,000	—	31 Dec 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.41%	179,174	$15,652,000	—	31 Dec 2019	13F
Prosight Management, LP	13F	Company	0.37%	161,195	$14,198,000	—	31 Dec 2019	13F
Greylin Investment Management, Inc	13F	Company	0.36%	157,216	$13,848,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.35%	153,885	$13,555,000	—	31 Dec 2019	13F
Atom Investors LP	13F	Company	0.35%	153,706	$13,538,000	—	31 Dec 2019	13F
Gamma As Sector	13F	Individual	0.34%	150,615	$13,266,000	—	31 Dec 2019	13F
Tamarack Advisers, LP	13F	Company	0.34%	151,400	$13,090,000	—	31 Dec 2019	13F
Sio Capital Management, LLC	13F	Company	0.3%	132,664	$11,685,000	—	31 Dec 2019	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.29%	128,000	$11,274,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0.29%	126,780	$11,167,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.28%	123,495	$10,878,000	—	31 Dec 2019	13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2020

As of 31 Mar 2020, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 293 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,930,204 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Consonance Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., DIMENSIONAL FUND ADVISORS LP, and Palo Alto Investors LP. This page lists 293 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

313

Q1 2020 holders

293

Holder diff

-20

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.